European perspective on the management of rheumatoid arthritis: clinical utility of tofacitinib
Paweł Kawalec,1 Katarzyna Śladowska,2 Iwona Malinowska-Lipień,3 Tomasz Brzostek,3 Maria Kózka4 1Drug Management Department, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, 2Department of Experimental Hematology, Institute of Zoology and Biomedical Res...
Saved in:
Main Authors: | Kawalec P (Author), Śladowska K (Author), Malinowska-Lipień I (Author), Brzostek T (Author), Kózka M (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New alternative in the treatment of rheumatoid arthritis: clinical utility of baricitinib
by: Kawalec P, et al.
Published: (2019) -
Clinical utility of the oral JAK inhibitor tofacitinib in the treatment of rheumatoid arthritis
by: Cutolo M, et al.
Published: (2013) -
Clinical scenarios-based guide for tofacitinib in rheumatoid arthritis
by: Mahta Mortezavi, et al.
Published: (2023) -
Use of YAKVINUS® (tofacitinib) for the treatment of rheumatoid arthritis
by: article Editorial
Published: (2018) -
Nurses' intention to leave their jobs in relation to work environment factors in Polish hospitals: Cross-sectional study
by: Iwona Malinowska-Lipień, et al.
Published: (2023)